PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17262218-4	2007	Treatment of hepatocytes with 800 microM CdCl(2) for 3 h caused significant reduction in cell viability in association with the increased levels of glutamate pyruvate transaminase (GPT) and alkaline phosphatase (ALP) leakage.	cdcl	41-45	glutamic pyruvic transaminase, soluble	Mus musculus	148-179	
17262218-4	2007	Treatment of hepatocytes with 800 microM CdCl(2) for 3 h caused significant reduction in cell viability in association with the increased levels of glutamate pyruvate transaminase (GPT) and alkaline phosphatase (ALP) leakage.	cdcl	41-45	glutamic pyruvic transaminase, soluble	Mus musculus	181-184	
21420465-4	2011	Administration of cadmium (30 muM), in the form of chloride (CdCl(2)) for 2h, significantly enhanced the ALT, ALP and LDH leakage, increased reactive oxygen species (ROS) production, reduced hepatocytes viability and altered the antioxidant status of hepatocytes by reducing intracellular GSH level, anti-oxidant enzymes activity and increasing intracellular GSSG and lipid peroxidation.	cdcl	61-65	glutamic pyruvic transaminase, soluble	Mus musculus	105-108	
19747628-8	2009	(PhSe)(2) protected against the increase in plasma AST, ALT and LDH activities caused by CdCl(2).	cdcl	89-93	glutamic pyruvic transaminase, soluble	Mus musculus	56-59